Elliott Wave view on Facebook (ticker FB) suggests that the rally from March 19, 2019 low is unfolding as an impulse Elliott Wave structure. In the 1 hour chart below, we can see wave (2) of this impulse...
Sony Corporation (NYSE: SNE) is a Japanese multinational conglomerate corporation. The Company has a diversified business primarily focused on the Electronics, Games, Entertainment and Financial Services. In this article, we’ll be looking at the technical Elliott Wave structure of...
Welcome traders, today we will look at a couple of USDSEK pair charts.The following analysis will show how profitable and efficient it can be to trade with our philosophy and basic Elliott Wave analysis. First of all, we start...
GBPJPY Technical Analysis April 10/2019 GBPJPY : Bearish market patterns can be seen on the GBPJPY 4 hour chart. In the chart below a blue bearish Head and Shoulders pattern is visible and price has already broken...
Short Term Elliott Wave view on Nikkei Futures suggests the pullback to 20704 ended wave (2). The Index then resumed higher in wave (3) which ended at 21985. The internal of wave (3) subdivided as an impulse Elliott...
Elliott Wave view on FTSE calls the rally from February 28, 2019 low (7041) as an impulse Elliott Wave structure. An impulse is a 5 waves structure with wave 1, 3, and 5 all subdivide in 5 waves...
Welcome traders, today we look at a couple of 30-min Coffee futures (KC_F) charts and its price action within hours. The following analysis will show how profitable and efficient it can be to trade with our philosophy and...
Hello fellow traders. In this technical blog we’re going to take a quick look at the Elliott Wave charts of GBPCAD. As our members know GBPCAD is showing incomplete bullish sequences in the cycle from the August...
Hello fellow traders. Today, I want to share some Elliott Wave charts of the BABA stockwhich we presented to our members in the past. Below, you see the 1-hour updated chart presented to our clients on the 03/28/19....
Biogen Incorporation (ticker symbol: BIIB) is an American multinational biotechnology company specialized in discovery, development, manufacturing, and delivery of therapies for the treatment of neurogenetics, hematologic and autoimmune disease. The company currently employs 7800 people approximately. The...
